Antileukotriene drugs: clinical application, effectiveness and safety.
about
Antileukotriene agents compared with placebo in children and adults with mild asthmaStatins as potential therapeutic drug for asthma?Identification of common biological pathways and drug targets across multiple respiratory viruses based on human host gene expression analysisDifferential inhibitory effects of CysLT(1) receptor antagonists on P2Y(6) receptor-mediated signaling and ion transport in human bronchial epithelia.Gene expression analyses in Atlantic salmon challenged with infectious salmon anemia virus reveal differences between individuals with early, intermediate and late mortalityLeukotriene receptor antagonists for chronic urticaria: a systematic review.Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a.Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell functionMALDI imaging MS of phospholipids in the mouse lungThe infectious march: the complex interaction between microbes and the immune system in asthma.Exercise-induced asthma: critical analysis of the protective role of montelukastAssociation between leukotriene-modifying agents and suicide: what is the evidence?Prostaglandin D2-supplemented "functional eicosanoid testing and typing" assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation disease: an explorative diagnostic study.Cysteinyl leukotriene 1 receptor expression associated with bronchial inflammation in severe exacerbations of COPDAnti-inflammatory effects of montelukast on smoke-induced lung injury in rats.The science behind dietary omega-3 fatty acidsDietary and Lifestyle Changes in the Treatment of a 23-Year-Old Female Patient With Migraine.A Case of Pranlukast-Induced Anaphylactic Shock.Association between allergic rhinitis and migraine.Montelukast inhibits neutrophil pro-inflammatory activity by a cyclic AMP-dependent mechanismTargeting the airway smooth muscle for asthma treatment.Leukotrienes in atherosclerosis: new target insights and future therapy perspectives.Effects of Singulair (montelukast) treatment for capsular contracture.Montelukast for the treatment of asthma in the adult population.Diagnosis, progression patterns and prognostication in mastocytosis.Dietary omega-3 PUFA and health: stearidonic acid-containing seed oils as effective and sustainable alternatives to traditional marine oils.The Effectiveness of Anti-leukotriene Agents in Patients with COPD: A Systemic Review and Meta-analysis.Lipidomic characterization and localization of phospholipids in the human lung.Effect of Zafirlukast on improving lung function in patients with chronic obstructive pulmonary diseases.Inhibition of 5-lipoxygenase and skin inflammation by the aerial parts of Artemisia capillaris and its constituents.Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor.Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases.Effects of Asian Dust Particles on the Early-Stage Antigen-Induced Immune Response of Asthma in NC/Nga Mice.Treatment with the leukotriene inhibitor montelukast for 10 days attenuates portal hypertension in rat liver cirrhosis.Effects of Montelukast on free radical production in whole blood and isolated human polymorphonuclear neutrophils (PMNs) in asthmatic children.Leukotriene receptor antagonism may not be effective in atopic dermatitis treatment after all.Effects of zafirlukast on capsular contracture: long-term results.The Approach of Conformational Chimeras to Model the Role of Proline-Containing Helices on GPCR Mobility: the Fertile Case of Cys-LTR1Effects of a cysteinyl leukotriene dual 1/2 receptor antagonist on antigen-induced airway hypersensitivity and airway inflammation in a guinea pig asthma model
P2860
Q24187545-0416FC25-4169-4C49-B94E-7374A97CAA28Q26864029-742EF8AD-C50A-4D1B-8A3A-18B77BE0CBAFQ28481496-0BED9950-9C23-4F32-9A73-43A738AC32E8Q31027582-F3BDBA77-DEE8-47B8-B4FE-573D108D4E0AQ33329258-8BC74266-1897-4868-B138-B5F6D3CD47E3Q33593785-37FBE1D4-2AAC-47EB-A849-E98274477047Q33625259-B75E5055-CEF8-4136-84F5-9259EAFE27CDQ33757657-245B8614-2A4E-47DF-B2A8-B56F9B2CCE62Q33878265-5500FA6F-67ED-411B-90CC-51323DA4C4B3Q34356430-33BC447D-ECA4-4973-8ACC-16B7953B918DQ34623842-4C55CAEC-611B-4B32-90D4-B5D5757B7E85Q34630067-92C1E42F-B8D3-4005-A79A-9EA4E88DE5F0Q34812525-74C9C4A1-0D5B-432B-A45D-756C68F5FFC5Q36181801-8C3B91D8-C59B-433E-9DD2-677B7037B53DQ36293948-69A0B2C8-BB17-4E64-AD39-6D5F6DDCF24EQ36327949-2FBE4713-6E06-4848-BE77-22A702DC07A4Q36387731-7E916CD3-2494-4364-A821-D20F1D66B1A1Q36636612-8FDAFB56-93D2-4F35-AF93-765F27173D38Q36789832-35AD5A3B-AAAE-4755-AB5B-24FC2F1E96DBQ37230838-D8D8CEDC-CD0F-4CFB-918B-B9EAF94428EEQ37393160-0E7B8221-803F-4B7E-99C6-9CD41C2CA216Q37691248-026C6B17-6A36-4459-A297-F54C5BC61029Q37769992-13857A85-F1E7-4CF1-B885-AB5BB92B7126Q37903337-AD4245EB-1097-4BBB-B613-B7D5A6ECBDD4Q38025156-F347F9B7-CEBE-444E-8311-AE771EFC3569Q38082480-D0E8AFFA-87C5-4B8A-A222-7BAEFB2F3E27Q38478483-02BD07FF-A42F-4255-8296-ADC2C567C2C9Q38916413-C452A098-CDE1-4CF9-8398-631F3F6B6C32Q39373760-5AE258DF-531E-4515-A66D-1D0FBD25B9E1Q39462796-0C85EDFC-8BDB-4F4B-95A9-3603321B6837Q39710240-E83DA85F-9DAF-4D9E-AA8F-2C7ECC8483FBQ41432422-0B4BF941-90D0-4502-BBD4-785EBB252DB9Q42361359-A78518EA-95A7-4B44-A7AF-F0766A11F152Q42472251-43EAB488-AF35-45E1-A201-90D9EA942208Q42557333-F479D6F7-CDF9-4BA1-9B34-6BBE02150487Q48346505-5FA52B0E-B762-47BC-90CB-D59397FEFD02Q51282357-AFB2CBFF-80FB-4900-8728-CF1341C7558FQ57012489-B25F8278-44C7-4695-90B4-BA5B0C8F240DQ57099569-625BC16C-5E7E-4A1E-A9F7-99E13CAB38FA
P2860
Antileukotriene drugs: clinical application, effectiveness and safety.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Antileukotriene drugs: clinical application, effectiveness and safety.
@en
type
label
Antileukotriene drugs: clinical application, effectiveness and safety.
@en
prefLabel
Antileukotriene drugs: clinical application, effectiveness and safety.
@en
P2093
P1476
Antileukotriene drugs: clinical application, effectiveness and safety.
@en
P2093
Bucciarelli T
D'Orazio N
Riccioni G
P304
P356
10.2174/092986707781368522
P577
2007-01-01T00:00:00Z